𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Status and expression of the p16INK4 gene in human thyroid tumors and thyroid-tumor cell lines

✍ Scribed by Viola Calabrò; Maria Strazzullo; Girolama La Mantia; Monica Fedele; Christian Paulin; Alfredo Fusco; Luigi Lania


Publisher
John Wiley and Sons
Year
1996
Tongue
French
Weight
648 KB
Volume
67
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


The p 16INK4 tumor-suppressor gene (also known as CDKNZ, CDK41 and MTSI) encodes a negative regulator of the cell cycle. This gene, located in 9pZ I, is mutated or homozygously deleted in a high percentage of tumor cell lines and specific types of primary tumors. We have examined the status of the p16INK4 gene in 31 thyroid tumors and 7 thyroid cell lines. No DNA abnormalities were found in primary tumors. Conversely, p16INK4 gene structural alterations, deletions and point mutations were found in 4 thyroid cell lines. The expression of the 2 different p16lNK4 mRNAs, the p Ibo! and p 168 transcripts, was determined by RNA-PCR experiments. All the primary thyroid tumors expressed the 8 transcript, while the p I6a was barely detectable. The thyroid cell lines always expressed the p168 transcript, while the o! transcript was absent or, whenever present, coded for a mutated form of the p16INK4 gene roduct. Taken directly involved in the process of thyroid-tumor development, but it probably gives cells in tissue culture a selective growth advantage. o 1996 Wilq-Liss, Inc. together, our results suggest that loss of pl6INK . Y function is not


📜 SIMILAR VOLUMES


Genetic and epigenetic alterations of th
✍ Rossella Elisei; Masaaki Shiohara; H. Phillip Koeffler; James A. Fagin 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 2 views

## Background: D-type cyclins, in association with the cyclin-dependent kinases cdk4 and cdk6, promote progression through the g1 phase of the cell cycle. cdk activity is modulated by inhibitors such as p15ink4b and p16ink4a. loss of function of p15ink4b and p16ink4a (multiple tumor suppressor-i an

Expression of the p16INK4a gene and meth
✍ Kanya Honoki; Toshifumi Tsujiuchi; Toshio Mori; Kazuhiro Yoshitani; Masahiro Tsu 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

## Abstract Loss of p16^INK4a^ protein expression has frequently been related to DNA methylation in association with gene silencing. Although the methylation status of exon1α for p16^INK4a^ involvement in various cancers has been extensively analyzed, it has been pointed out that some inconsistenci

Differential retinoblastoma and p16INK4A
✍ Hirotoshi Dosaka-Akita; Philip T. Cagle; Hiromitsu Hiroumi; Masahiro Fujita; Mot 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB 👁 2 views

## BACKGROUND. Neuroendocrine neoplasms of the lung represent a wide spectrum of phenotypically and biologically distinct entities. Their histopathologic diagnosis, which carries therapeutic and prognostic significance, may sometimes be difficult because of their overlapping features. We previously

Expression of Aurora kinases in human th
✍ Salvatore Ulisse; Jean-Guy Delcros; Enke Baldini; Matteo Toller; Francesco Curci 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 414 KB 👁 1 views

## Abstract The Aurora kinases are involved in the regulation of cell cycle progression, and alterations in their expression have been shown to associate with cell malignant transformation. In the present study, we demonstrated that human thyrocytes express all 3 Aurora kinases (A, B and C) at both

Loss of expression of the p16INK4/CDKN2
✍ Lauri Talve; Ilari Sauroja; Yrjö Collan; Kari Punnonen; Tauno Ekfors 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 155 KB 👁 2 views

The G 1 /S checkpoint of the cell cycle is regulated by p16, p53 and RB tumor suppressor genes. Loss of expression of the p16 INK4 tumor suppressor protein, the product of the CDKN2 gene, has been associated with a wide variety of human malignancies. Mutations, loss of heterozygosity and deletions o